INOVIO PHARMACEUTICALS, INC. Increase (Decrease) in Contract with Customer, Liability
INOVIO PHARMACEUTICALS, INC. (INO) reported Increase (Decrease) in Contract with Customer, Liability of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-06.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2024-03-06
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in contract with customer, liability for the quarter ending 2023-12-31 was $0.00.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in contract with customer, liability for the quarter ending 2023-09-30 was $0.00.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in contract with customer, liability for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in contract with customer, liability for the quarter ending 2023-03-31 was $0.00.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in contract with customer, liability for fiscal 2023 was $0.00.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in contract with customer, liability for fiscal 2022 was -$85.99K.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in contract with customer, liability for fiscal 2021 was -$39.85K.
- INOVIO PHARMACEUTICALS, INC. increase (decrease) in contract with customer, liability for fiscal 2020 was -$62.35K.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 3 month as first filed | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 6 month as first filed | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month | Increase (Decrease) in Contract with Customer, Liability 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | $0.00 derived: sum of 2 quarters · filed 2024-03-06 | $0.00 derived: sum of 3 quarters · filed 2024-03-06 | $0.00 10-K · filed 2024-03-06 | |||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | $0.00 derived: sum of 4 quarters · filed 2024-03-06 | |||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $0.00 10-Q · filed 2023-08-09 | $0.00 derived: sum of 3 quarters · filed 2024-03-06 | -$9.04M derived: sum of 4 quarters · filed 2024-03-06 | |||
| 2023-03-31 | $0.00 10-Q · filed 2023-05-10 | $0.00 derived: sum of 2 quarters · filed 2024-03-06 | -$9.04M derived: sum of 3 quarters · filed 2024-03-06 | -$76.03K derived: sum of 4 quarters · filed 2024-03-06 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | -$9.04M derived: sum of 2 quarters · filed 2024-03-06 | -$76.03K derived: sum of 3 quarters · filed 2024-03-06 | -$85.99K 10-K · filed 2024-03-06 | |||
| 2022-09-30 | -$9.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$76.03K derived: sum of 2 quarters · filed 2023-11-09 | -$85.99K 10-Q · filed 2023-11-09 | -$145.95K derived: sum of 4 quarters · filed 2024-03-06 | |||
| 2022-06-30 | $8.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $8.95M 10-Q · filed 2023-08-09 | $8.89M derived: sum of 3 quarters · filed 2024-03-06 | $8.86M derived: sum of 4 quarters · filed 2024-03-06 | |||
| 2022-03-31 | -$9.96K 10-Q · filed 2023-05-10 | -$69.93K derived: sum of 2 quarters · filed 2024-03-06 | -$98.64K derived: sum of 3 quarters · filed 2024-03-06 | $22.65K derived: sum of 4 quarters · filed 2024-03-06 | |||
| 2021-12-31 | -$59.96K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | -$88.68K derived: sum of 2 quarters · filed 2024-03-06 | $32.61K derived: sum of 3 quarters · filed 2024-03-06 | -$39.85K 10-K · filed 2024-03-06 | |||
| 2021-09-30 | -$28.71K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $92.57K derived: sum of 2 quarters · filed 2022-11-08 | $20.11K 10-Q · filed 2022-11-08 | -$9.13K derived: sum of 4 quarters · filed 2023-03-01 | |||
| 2021-06-30 | $121.29K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $48.82K 10-Q · filed 2022-08-09 | $55.07K 10-Q · filed 2021-08-09 | $19.59K derived: sum of 3 quarters · filed 2023-03-01 | $78.90K derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2021-03-31 | -$72.46K 10-Q · filed 2022-05-10 | -$34.96K 10-Q · filed 2021-05-10 | -$101.70K derived: sum of 2 quarters · filed 2023-03-01 | -$42.39K derived: sum of 3 quarters · filed 2023-03-01 | -$108.52K derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2020-12-31 | -$29.24K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $30.07K derived: sum of 2 quarters · filed 2023-03-01 | -$36.06K derived: sum of 3 quarters · filed 2023-03-01 | -$62.35K 10-K · filed 2023-03-01 | -$68.08K 10-K · filed 2021-03-01 | ||
| 2020-09-30 | $59.31K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$6.82K derived: sum of 2 quarters · filed 2021-11-09 | -$33.12K 10-Q · filed 2021-11-09 | -$69.41K derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-06-30 | -$66.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$92.43K 10-Q · filed 2021-08-09 | -$128.72K derived: sum of 3 quarters · filed 2022-03-01 | -$135.83K derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2020-03-31 | -$26.30K 10-Q · filed 2021-05-10 | -$62.59K derived: sum of 2 quarters · filed 2022-03-01 | -$69.70K derived: sum of 3 quarters · filed 2022-03-01 | -$84.87K derived: sum of 4 quarters · filed 2022-03-01 | |||
| 2019-12-31 | -$36.30K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$43.40K derived: sum of 2 quarters · filed 2022-03-01 | -$58.58K derived: sum of 3 quarters · filed 2022-03-01 | -$180.45K 10-K · filed 2022-03-01 | |||
| 2019-09-30 | -$7.11K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$22.28K derived: sum of 2 quarters · filed 2020-11-09 | -$144.15K 10-Q · filed 2020-11-09 | -$154.25K derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2019-06-30 | -$15.17K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$137.05K 10-Q · filed 2020-08-10 | -$147.14K derived: sum of 3 quarters · filed 2021-03-01 | -$700.19K derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2019-03-31 | -$121.87K 10-Q · filed 2020-05-11 | -$131.96K derived: sum of 2 quarters · filed 2021-03-01 | -$685.02K derived: sum of 3 quarters · filed 2021-03-01 | -$24.04M derived: sum of 4 quarters · filed 2021-03-01 | |||
| 2018-12-31 | -$10.09K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$563.15K derived: sum of 2 quarters · filed 2021-03-01 | -$23.92M derived: sum of 3 quarters · filed 2021-03-01 | -$1.02M 10-K · filed 2021-03-01 | |||
| 2018-09-30 | -$553.06K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$23.91M derived: sum of 2 quarters · filed 2019-11-12 | -$1.01M 10-Q · filed 2019-11-12 | $40.33K derived: sum of 4 quarters · filed 2020-03-12 | |||
| 2018-06-30 | -$23.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$453.69K 10-Q · filed 2019-08-08 | $593.39K derived: sum of 3 quarters · filed 2020-03-12 | $182.89K derived: sum of 4 quarters · filed 2020-03-12 | |||
| 2018-03-31 | $22.90M 10-Q · filed 2019-05-09 | $23.95M derived: sum of 2 quarters · filed 2020-03-12 | $23.54M derived: sum of 3 quarters · filed 2020-03-12 | ||||
| 2017-12-31 | $1.05M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $636.58K derived: sum of 2 quarters · filed 2020-03-12 | -$13.69M 10-K · filed 2020-03-12 | ||||
| 2017-09-30 | -$410.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$14.74M 10-Q · filed 2018-11-08 | |||||
| 2017-06-30 | -$14.33M 10-Q · filed 2018-08-07 | ||||||
| 2016-12-31 | $1.53M 10-K · filed 2019-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |